Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-12-04

Clinical Trial Update: Topical 5-ALA-PDT With Blu-U Therapy Versus Topical 5-ALA With Pulse Dye Laser In Treating Recalcitrant Acne Vulgaris [NA]

View source ↗

Summary

A clinical trial comparing topical 5-ALA-PDT with Blu-U therapy to topical 5-ALA with pulse dye laser for recalcitrant acne vulgaris has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-aminolevulinic acid (5-aminolevulinic acid)

Snippet

Sponsor: University of Chicago | Conditions: Acne Vulgaris | NA | Status: WITHDRAWN